BDABF (Boule Diagnostics AB) Cyclically Adjusted Book per Share: $22.75 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BDABF Boule Diagnostics AB BDABF
47 GF Score
Price $7.84
GF Value $14.73
! 2 Warning Signs
View Full Analysis

What is Boule Diagnostics AB Cyclically Adjusted Book per Share?

Boule Diagnostics AB BDABF 47 Cyclically Adjusted Book per Share is $22.75 as of Mar. 2026. GuruFocus rates BDABF with a GF Score™ of 47/100 and a GF Value™ of $14.73. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Boule Diagnostics AB's adjusted book value per share for the three months ended in Mar. 2026 was $0.474. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $22.75 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Boule Diagnostics AB's average Cyclically Adjusted Book Growth Rate was -3.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 2.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Boule Diagnostics AB was 10.30% per year. The lowest was 2.30% per year. And the median was 8.95% per year.

As of today (2026-07-14), Boule Diagnostics AB's current stock price is $7.84. Boule Diagnostics AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $22.75. Boule Diagnostics AB's Cyclically Adjusted PB Ratio of today is 0.34.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boule Diagnostics AB was 6.71. The lowest was 0.27. And the median was 1.13.


Boule Diagnostics AB  (OTCPK:BDABF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Boule Diagnostics AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=7.84/22.75
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Boule Diagnostics AB was 6.71. The lowest was 0.27. And the median was 1.13.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Boule Diagnostics AB Cyclically Adjusted Book per Share Related Terms


Boule Diagnostics AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Boule Diagnostics AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boule Diagnostics AB Cyclically Adjusted Book per Share Chart

Boule Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.13 5.62 8.20 10.50 18.47

Boule Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.65 10.65 17.66 18.47 22.75

BDABF vs ABT, SYK, MDT: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Boule Diagnostics AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boule Diagnostics AB Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boule Diagnostics AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Boule Diagnostics AB's Cyclically Adjusted PB Ratio falls into.


BDABF
47GF Score
Boule Diagnostics AB BDABF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boule Diagnostics AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Boule Diagnostics AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.474/133.5600*133.5600
=0.474

Current CPI (Mar. 2026) = 133.5600.

Boule Diagnostics AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.916 101.019 1.211
201609 0.984 101.138 1.299
201612 0.939 102.022 1.229
201703 0.999 102.022 1.308
201706 0.953 102.752 1.239
201709 1.140 103.279 1.474
201712 1.137 103.793 1.463
201803 1.232 103.962 1.583
201806 1.203 104.875 1.532
201809 1.219 105.679 1.541
201812 1.215 105.912 1.532
201903 1.234 105.886 1.557
201906 1.177 106.742 1.473
201909 1.252 107.214 1.560
201912 1.287 107.766 1.595
202003 1.309 106.563 1.641
202006 1.166 107.498 1.449
202009 1.291 107.635 1.602
202012 1.174 108.296 1.448
202103 1.185 108.360 1.461
202106 1.139 108.928 1.397
202109 1.156 110.338 1.399
202112 1.187 112.486 1.409
202203 1.158 114.825 1.347
202206 1.138 118.384 1.284
202209 1.125 122.296 1.229
202212 1.148 126.365 1.213
202303 1.149 127.042 1.208
202306 1.150 129.407 1.187
202309 1.126 130.224 1.155
202312 1.193 131.912 1.208
202403 1.232 132.205 1.245
202406 1.219 132.716 1.227
202409 0.642 132.304 0.648
202412 0.460 132.987 0.462
202503 0.439 132.825 0.441
202506 0.436 133.699 0.436
202509 0.463 133.480 0.463
202512 0.465 133.390 0.466
202603 0.474 133.560 0.474

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $22.75 mean?
Boule Diagnostics AB (BDABF) has a Cyclically Adjusted Book per Share of $22.75 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boule Diagnostics AB and its competitors.
Is Boule Diagnostics AB's Cyclically Adjusted Book per Share too high?
Boule Diagnostics AB's current Cyclically Adjusted Book per Share is $22.75. Overall, Boule Diagnostics AB has a GF Score™ of 47/100, reflecting its overall financial health beyond just this single metric.
How does Boule Diagnostics AB's Cyclically Adjusted Book per Share compare to ABT and SYK?
Boule Diagnostics AB's Cyclically Adjusted Book per Share of $22.75 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Boule Diagnostics AB and its competitors. Boule Diagnostics AB's current Cyclically Adjusted Book per Share is $22.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boule Diagnostics AB stock overvalued right now?
Boule Diagnostics AB (BDABF) has a current Cyclically Adjusted Book per Share of $22.75. The stock's GF Value™ is $14.73, compared to a current price of $7.84 — trading 46.8% below its estimated fair value. The current Cyclically Adjusted Book per Share is $22.75. Boule Diagnostics AB's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Boule Diagnostics AB (BDABF), the current Cyclically Adjusted Book per Share is $22.75 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boule Diagnostics AB (BDABF) Overvalued in 2026?

Based on GuruFocus' analysis, Boule Diagnostics AB stock appears to be undervalued. The current stock price of $7.84 is trading 46.8% below its estimated GF Value™ of $14.73.

Key valuation signals for BDABF:

  • Cyclically Adjusted Book per Share: $22.75
  • GF Value™: $14.73 vs. price of $7.84 (46.8% below fair value)
  • GF Score™: 47/100 with 2 warning signs

No single metric tells the full story. See the BDABF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boule Diagnostics AB Business Description

Other Exchanges BOUL:Sweden
Address Fagerstagatan 7, Spanga, SWE, SE-163 53
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. the company operating through two complementary business segments: Diagnostics and OEM CDS. Through its subsidiaries, the company operates in USA ,Asia, Eastern Europe, Latin America Western Europe and Africa / Middle East. The majority revenue is generated from Asia.
47GF Score

Get the complete analysis for BDABF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.84
Price
$14.73
GF Value